Payen, J-F <br/><br/>
Reduced mortality by meeting guideline criteria before using recombinant activated factor VII in severe trauma patients with massive bleeding.  [electronic resource] 

 -  British journal of anaesthesia  Oct 2016 
 - 470-476 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1471-6771 
<br/><br/><label>Standard No.: </label>10.1093/bja/aew276  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Factor VIIa--adverse effects<br/>Female<br/>Guideline Adherence<br/>Hemorrhage--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Practice Guidelines as Topic<br/>Prospective Studies<br/>Recombinant Proteins--adverse effects<br/>Wounds and Injuries--mortality